跳至主要内容
临床试验/CTRI/2021/07/035182
CTRI/2021/07/035182尚未招募不适用

Efficacy of Adjunctive Theta Burst Transcranial Magnetic Stimulation in Bipolar Depression -A Randomized Placebo Controlled Study

SGRRIMHS1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年9月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To assess and compare the change in Depressive symptoms in Bipolar Depression among active and placebo group

研究概览

简要总结

This study aims to investigate the clinical efficacy of continuous theta burst stimulation (cTBS) on the right DLPFC  in bipolar depression. For this study Bipolar depressed patients will be selected by a certified psychiatrist. The presence of exclusion criteria will be evaluated. Eligible patients will undergo Baseline clinical assessments and research assessments. TBS involves applying triple-pulse 50 Hz bursts given at a rate of 5 Hz uninterrupted trains (1). Patients will be treated with in total 15  (3 sessions per day)continuous Theta Burst Stimulation (cTBS) session (200 pulses per session) over the right dorsolateral prefrontal cortex, which will be spread over 5 days a week. A stimulation intensity of 80% of the subject’s  motor threshold (MT) of the right abductor pollicis brevis muscle will used. Patients will be randomized to receive either the real cTBS or sham treatment. Sham stimulation will be applied with a sham coil. The sham coil produces identical sounds but is not associated with a stimulus sensation compared to the coil delivering real stimulation cTBS. Two post-treatment assessment  will take place respectively 7 days and 21 days post initiation of treatment . 

1.  (1)   Chung S, Hoy K , Fitzgerald P. Theta-burst stimulation: a new form of TMS     treatment for depression. Depression and Anxiety *.*2014;32(3): 182-192.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, variable
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 59.00 Year(s)(—)
性别
All

入选标准

  • Diagnosis of moderate to severe Bipolar disorder with current episode of Depression 2) Baseline HAM-D Score >18 3) Right Handed nor Mo tensive patient.

排除标准

  • Neurological Disorder such as epilepsy,organic brain damage or any neurological procedure.
  • Pacemakers or other metal parts in the body 3) ECT in the past 6 months 4) Any comorbid Psychosis 5) History of non response to rTMS treatment 6) Alcohol or any other substance dependence except Nicotine and Caffine.

结局指标

主要结局

To assess and compare the change in Depressive symptoms in Bipolar Depression among active and placebo group

时间窗: Screening ,Baseline ,7th Day post initiation of therapy, 21st Day post initiation of therapy

次要结局

  • To assess and compare change in anxiety symptoms in bipolar depression(Baseline ,7th Day post initiation of therapy, 21st Day post initiation of therapy)
  • To assess and compare change in quality of life in bipolar depression(Baseline ,7th Day post initiation of therapy, 21st Day post initiation of therapy)
  • To assess and compare change in sexual dysfunction in bipolar depression(Baseline ,7th Day post initiation of therapy, 21st Day post initiation of therapy)

研究者

发起方
SGRRIMHS
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验